Press release
Ophthalmic Devices Global Market Analysis, Trends, Growth, Research And Forecast 2033
Ophthalmic Devices Global Market Analysis
According to The Business Research Company's, The ophthalmic devices market size has grown rapidly in recent years. It will grow from $41.18 billion in 2023 to $45.6 billion in 2024 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to aging population, increasing eye diseases, regulatory changes, the expansion and improvement of healthcare infrastructure,.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/ophthalmic-devices-global-market-report
Market Drivers and Trends:
An increasing geriatric population is expected to boost the growth of the ophthalmic device market going forward. Geriatrics is the medical care of older people, a difficult age category to define accurately. The growing geriatric population is increasing the demand for ophthalmic devices, as they are more susceptible to age-related ophthalmic disorders. For instance, in October 2022, according to the data released by the World Trade Organization, a US-based international organization, from 2020 to 2021, the proportion of the population aged 60 increased from 1 billion to 1.4 billion. By 2050, the world's population of adults aged 60 and older will have doubled (to 2.1 billion). The number of people aged 80 or more is predicted to triple between 2020 and 2050, reaching 426 million. Therefore, the increasing geriatric population is driving the growth of the ophthalmic device market.
Major companies operating in the ophthalmic devices market are focusing on developing innovative products to sustain their position in the market. They are investing in research and development to introduce innovative products and expand their market share. For instance, in May 2023, Sight Sciences Inc, a US-based eyecare technology company focused on creating innovative solutions intended to transform care and improve patients' lives, announced the development of two innovative ophthalmic systems, two of its proprietary glaucoma and dry eye technologies, the OMNI Surgical System and the TearCare System. The OMNI Surgical System technology will facilitate surgeons' ability to perform minimally invasive, implant-free glaucoma procedures in adults with primary open-angle glaucoma. The TearCare System technology for dry eye enables an interventional eyelid procedure for diseased meibomian glands and is indicated for the application of localized heat therapy in adult patients with evaporative dry eye disease because of meibomian gland dysfunction.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=1970&type=smp
Major Key Players of the Market:
Luxottica Group S.p.A.; Johnson & Johnson; Hoya Corporation; CooperVision AG; Bausch Health Companies Inc.; Carl Zeiss AG; Flex Ltd.; Nidek Co. Ltd.; Topcon Corporation; Rostec State Corporation; Alcon Inc.; EssilorLuxottica; Novartis AG; Pfizer Inc.; Regeneron Pharmaceuticals Inc.; Roche Holding AG; Takeda Pharmaceuticals; AbbVie Inc.; Otsuka Pharmaceutical Co. Ltd.; Edwards Lifesciences Corp.; Santen Pharmaceutical Co. Ltd.; Rohto Pharmaceutical Co. Ltd.; Veeva System Inc.; Recipharm AB; Menicon Co. Ltd.; Chengdu Kanghong Pharmaceutical; Bangladesh Export Import Company Limited; Glaukos Corporation; STAAR Surgical Company; Omeros Corporation; Aerie Pharmaceuticals Inc.; Alimera Sciences Inc.; Bora Pharmaceuticals Co. Ltd.; Iridex
Ophthalmic Devices Market 2024 Key Insights:
• The ophthalmic devices market size is expected to see grow to $66.1 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%.
• An increasing geriatric population is expected to boost the growth of the ophthalmic device market going forward. Geriatrics is the medical care of older people, a difficult age category to define accurately. The growing geriatric population is increasing the demand for ophthalmic devices, as they are more susceptible to age-related ophthalmic disorders. For instance, in October 2022, according to the data released by the World Trade Organization, a US-based international organization, from 2020 to 2021, the proportion of the population aged 60 increased from 1 billion to 1.4 billion. By 2050, the world's population of adults aged 60 and older will have doubled (to 2.1 billion). The number of people aged 80 or more is predicted to triple between 2020 and 2050, reaching 426 million. Therefore, the increasing geriatric population is driving the growth of the ophthalmic device market.
• Major companies operating in the ophthalmic devices market are focusing on developing innovative products to sustain their position in the market. They are investing in research and development to introduce innovative products and expand their market share. For instance, in May 2023, Sight Sciences Inc, a US-based eyecare technology company focused on creating innovative solutions intended to transform care and improve patients' lives, announced the development of two innovative ophthalmic systems, two of its proprietary glaucoma and dry eye technologies, the OMNI Surgical System and the TearCare System. The OMNI Surgical System technology will facilitate surgeons' ability to perform minimally invasive, implant-free glaucoma procedures in adults with primary open-angle glaucoma. The TearCare System technology for dry eye enables an interventional eyelid procedure for diseased meibomian glands and is indicated for the application of localized heat therapy in adult patients with evaporative dry eye disease because of meibomian gland dysfunction.
• North America was the largest region in the global ophthalmic devices market in 2023.
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=1970&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ophthalmic Devices Global Market Analysis, Trends, Growth, Research And Forecast 2033 here
News-ID: 3675219 • Views: …
More Releases from The Business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Pharmaceutical
Metronidazole Market 2023 Latest Innovations and Outlook By Players - Hongyuan P …
The Metronidazole Market 2023 study focuses on a global evaluation of information from the most recent market developments. The purpose of MarketsandResearch.biz is to offer the company's customers a comprehensive market overview to formulate development plans.
Designing of the report is done with the help of infographics, charts, and graphs. The report initially analyzes the various segments of the global Metronidazole market in a brief manner, which includes product types, applications.…
Hyperthyroidism Treatment Market Analytical Overview and Future | Merck, Herbran …
The Hyperthyroidism Treatment market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with development…
Mevastatin Market Is Booming Worldwide |Zhejiang Hisun Pharmaceutical, Guangdong …
Global Mevastatin Market Size research report 2022 offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. This study provides information about the sales and revenue during the historic and forecasted period of (2022 to 2028). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for…
Global Specialty Pharmaceutical Market Driving Future Growth on Specialty Pharma …
Global Specialty Pharmaceutical Industry Synopsis:
The Specialty Pharmaceutical Market report provides a detailed analysis of this business space. The market is analyzed in terms of production as well as consumption. Based on the production aspect, the report includes particulars pertaining to the manufacturing processes of the product, alongside revenue and gross margins of the respective manufacturers.
The Global Specialty Pharmaceutical Market will reach xxx Million USD in 2020 with CAGR xx%…
Metronidazole Market to 2023 (+5% CAGR Expected) Top Player Profiles – Hongyua …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR
Scope of the Report:
This report focuses on the Metronidazole in global market, especially in…
Metronidazole Market by Top Key Participant Hongyuan Pharmaceutical, Yinhe Aarti …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Get Sample Copy of this Report @ https://www.researchbeam.com/global-metronidazole-2018-by-manufacturers-regions-type-and-application-forecast-to-2023-market/request-sample?utm_source=Anil
Scope of the Report:
This report focuses on the Metronidazole in global market, especially in North…
